Diversity Management, News and Updates
Originally published on jnj.com. Up to 200,000 Regimens of Janssen’s Investigational Ebola Vaccine to be Supplied to Rwanda for Use in Border Region near Democratic Republic of the Congo (DRC) Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will provide up to 200,000 Ebola vaccine regimens to the…
Originally Published by Johnson & Johnson Johnson & Johnson today announced that its Janssen Pharmaceutical Companies have submitted Marketing Authorization Applications (MAAs) to the European Medicines Agency (EMA) seeking licensure for an investigational Ebola vaccine regimen for the prevention of Ebola Virus Disease (EVD) caused by Zaire ebolavirus species. Two MAAs…
Johnson & Johnson (No. 8 on the DiversityInc Top 50 Companies list) announced that Janssen Vaccines & Prevention B.V. (Janssen) has completed a submission to the World Health Organization (WHO) for Emergency Use Assessment and Listing (EUAL) for its investigational preventive Ebola prime-boost vaccine regimen. The EUAL is a special…
The aftermath of Donald Trump as the presumptive GOP nominee has left many Republicans in a quandary — many don’t want to be associated with Trump. South Carolina Sen. Lindsey Graham this week tweeted: “If we nominate Trump, we will get destroyed…….and we will deserve it.” He previously called Trump…
By Julissa Catalan A Texas community college will not admit international applicants if their country of origin has “confirmed Ebola cases,” even if the individuals are not at risk of being infected with the disease. Navarro Collegea community college 20 miles outside of Dallasissued multiple rejection letters to applicants with…